United States
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
40.50%
|
June 30, 2024 | USD 3.07 | 4.78% |
|
United States |
|
2 |
38.91%
|
Sept. 30, 2024 | USD 1.54 | 1.99% |
|
United States |
|
3 |
38.13%
|
Oct. 31, 2024 | USD 23.54 | -0.34% |
|
United States |
|
4 |
34.89%
|
Sept. 30, 2024 | USD 690.87 | -3.63% |
|
United States |
|
5 |
33.33%
|
Sept. 30, 2024 | USD 23.09 | 1.27% |
|
United States |
|
6 |
32.17%
|
Sept. 30, 2024 | USD 10.50 | -0.19% |
|
United States |
|
7 |
30.33%
|
Oct. 5, 2024 | USD 6.29 | -0.32% |
|
United States |
|
8 |
26.52%
|
Sept. 30, 2024 | USD 31.69 | 1.67% |
|
United States |
|
9 |
26.17%
|
Sept. 30, 2024 | USD 159.74 | 0.57% |
|
United States |
|
10 |
25.95%
|
Oct. 31, 2024 | USD 89.11 | -2.38% |
|
United States |
|
11 |
22.56%
|
Sept. 30, 2024 | USD 33.88 | -0.29% |
|
United States |
|
12 |
21.68%
|
Sept. 28, 2024 | USD 67.66 | 1.36% |
|
United States |
|
13 |
21.26%
|
Sept. 29, 2024 | USD 21.03 | 0.29% |
|
United States |
|
14 |
20.34%
|
Sept. 30, 2024 | USD 126.18 | 0.60% |
|
United States |
|
15 |
19.81%
|
Sept. 30, 2024 | USD 131.18 | 1.80% |
|
United States |
|
16 |
19.43%
|
Sept. 30, 2024 | USD 34.69 | 1.34% |
|
United States |
|
17 |
18.99%
|
Sept. 30, 2024 | USD 341.64 | 1.64% |
|
United States |
|
18 |
17.31%
|
Sept. 30, 2024 | USD 39.05 | 1.35% |
|
United States |
|
19 |
16.18%
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
20 |
15.87%
|
Sept. 30, 2024 | USD 4.92 | 2.71% |
|
United States |
|
21 |
15.47%
|
Sept. 30, 2024 | USD 9.77 | 4.38% |
|
United States |
|
22 |
14.78%
|
Sept. 30, 2024 | USD 131.48 | -0.48% |
|
United States |
|
23 |
14.24%
|
Sept. 30, 2024 | USD 6.74 | -0.44% |
|
United States |
|
24 |
14.20%
|
Sept. 30, 2024 | USD 69.55 | 1.92% |
|
United States |
|
25 |
13.10%
|
Sept. 28, 2024 | USD 53.35 | 0.58% |
|
United States |
|
26 |
12.95%
|
Sept. 28, 2024 | USD 33.55 | -1.35% |
|
United States |
|
27 |
12.15%
|
Sept. 30, 2024 | USD 9.14 | 0.44% |
|
United States |
|
28 |
11.71%
|
Sept. 30, 2024 | USD 73.87 | -1.51% |
|
United States |
|
29 |
10.57%
|
Sept. 30, 2024 | USD 11.14 | 1.09% |
|
United States |
|
30 |
9.69%
|
Sept. 30, 2024 | USD 32.37 | 1.35% |
|
United States |
|
31 |
9.65%
|
Sept. 30, 2024 | USD 3.21 | -5.87% |
|
United States |
|
32 |
9.26%
|
Sept. 27, 2024 | USD 21.65 | -3.69% |
|
United States |
|
33 |
8.54%
|
Nov. 2, 2024 | USD 35.48 | -0.95% |
|
United States |
|
34 |
8.04%
|
Sept. 30, 2024 | USD 25.46 | -2.64% |
|
United States |
|
35 |
6.93%
|
Sept. 30, 2024 | USD 14.00 | 0.29% |
|
United States |
|
36 |
6.73%
|
Dec. 31, 2023 | USD 0.85 | -0.08% |
|
United States |
|
37 |
6.69%
|
Sept. 30, 2024 | USD 3.50 | -4.11% |
|
United States |
|
38 |
6.28%
|
Sept. 30, 2024 | USD 1.52 | NA |
|
United States |
|
39 |
4.91%
|
Sept. 30, 2024 | USD 25.62 | 11.39% |
|
United States |
|
40 |
4.37%
|
Nov. 2, 2024 | USD 14.02 | -3.71% |
|
United States |
|
41 |
3.68%
|
Nov. 30, 2024 | USD 4.02 | -3.13% |
|
United States |
|
42 |
2.02%
|
Sept. 30, 2024 | USD 5.78 | -3.02% |
|
United States |
|
43 |
0.58%
|
Nov. 2, 2024 | USD 3.72 | 2.48% |
|
United States |
|
44 |
0.54%
|
Sept. 30, 2024 | USD 12.65 | -16.61% |
|
United States |
|
45 |
-0.52%
|
Sept. 30, 2024 | USD 6.87 | 0.59% |
|
United States |
|
46 |
-0.55%
|
Sept. 30, 2024 | USD 6.11 | 3.91% |
|
United States |
|
47 |
-1.05%
|
Sept. 30, 2024 | USD 24.60 | -1.95% |
|
United States |
|
48 |
-3.64%
|
March 31, 2024 | USD 3.77 | 3.00% |
|
United States |
|
49 |
-5.31%
|
Sept. 30, 2024 | USD 32.47 | 0.03% |
|
United States |
|
50 |
-6.09%
|
Sept. 30, 2024 | USD 2.95 | NA |
|
United States |
The Cosmetics company in United States with the highest EBITDA Margin is Waldencast plc (NasdaqCM: WALD) at 40.50%.
The Cosmetics company in United States with the lowest EBITDA Margin is Kala Pharmaceuticals, Inc. (NasdaqCM: KALA) at -46,920.00%.
The top 10 Cosmetics companies in United States by EBITDA Margin are Waldencast plc, Olaplex Holdings, Inc., Photronics, Inc., Regeneron Pharmaceuticals, Inc., Regis Corporation, United-Guardian, Inc., European Wax Center, Inc., Match Group, Inc., The Procter & Gamble Company and The Cooper Companies, Inc..
The bottom 10 Cosmetics companies in United States by EBITDA Margin are Kala Pharmaceuticals, Inc., VYNE Therapeutics Inc., Fortress Biotech, Inc., Arcutis Biotherapeutics, Inc., AVITA Medical, Inc., NEXGEL, Inc., Sonoma Pharmaceuticals, Inc., WW International, Inc., Biofrontera Inc. and Journey Medical Corporation.